Trump’s Prescription Drug Policy: Rhetoric vs. True Reform
Katherine O'Malley October 29, 2025
Trump’s drug pricing policy promises headlines but not savings – Americans still pay triple, while real reform remains out of reach.
Trump’s drug pricing policy promises headlines but not savings – Americans still pay triple, while real reform remains out of reach.
Prescription drug costs in America are too high – will Congress rein in the middlemen in the supply chain that contribute to this problem?
Can digital health platforms like Zocdoc and Solv help close care gaps for dual-eligible patients?
Cutting federal funding for the 9,000 public libraries serving as vital, local health hubs would negatively impact communities.
As the Inflation Reduction Act empowers Medicare to negotiate drug prices based in part on clinical benefit, and as the FDA more closely scrutinizes accelerated
The Trump is cutting the health care coverage, programs, and infrastructure older Americans rely on.
Pharmacy benefit managers (PBMs) have recently been the focus of media and legislation, but what do they actually do?
Improving dementia care coordination will help patients and caregivers, reduce health care use, and lower costs.
Although health care subscriptions offer convenience and access, they may reinforce disparities, particularly for low-income, uninsured, and high-need populations.
Long wait times in Veterans Health Administration can lead to poorer health outcomes. Research shows increasing provider supply may reduce delays and increase access.
Spending time in nature is one of the best things you can do for your health. Try telling that to the Trump admin.
New research reveals unethical practices exploit vulnerable patients in substance use disorder treatment, while state efforts lack sufficient enforcement, funding, and coordination.